Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




At Last, a Screening Test for Lung Cancer
Link ID 31608
Title At Last, a Screening Test for Lung Cancer
Url http://www.medscape.com/viewarticle/733742?src=rss
Description Dr. Mark Kris reports on the National Cancer Institute landmark study that found that use of low-dose helical CT scans provides a 20% reduction in mortality in current and previous smokers. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Dec 10, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Four Bad Actors Cause Most Infection-Related CancerFour Bad Actors Cause Most Infection-Related Canc
  And they are all preventable in some way. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Accelerated Approval of Bevacizumab for Breast Cancer
  Bevacizumab has received accelerated approval from the FDA for use in metastatic breast cancer in combination with paclitaxel chemotherapy. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Prevention of Bladder Toxicity From Cyclophosphamide -- What Do Rheumatologists Need to Do?
  Dr. Kevin Deane discusses a recent study reviewing the incidence and prevention of cyclophosphamide-related bladder toxicity. Medscape Rheumatology
Category:   Articles > Hematology-Oncology


4. Current Concepts of Anthracycline Cardiotoxicity: Pathogenesis, Diagnosis and Prevention
  Current approaches can reduce cardiac damage from these commonly used antineoplastic drugs, and current research is exploring new strategies for early identification and prevention. British Journal of Cardiology
Category:   Articles > Hematology-Oncology


5. Bevacizumab: Important Drug for NSCLCBevacizumab: Important Drug for NSCLC
  Dr. Mark Kris highlights the therapeutic benefits -- and toxicities -- associated with bevacizumab use in patients with non-small cell lung cancer. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS